Sol-Gel Technologies (NASDAQ:SLGL) Stock Price Up 5.2% – Time to Buy?

Shares of Sol-Gel Technologies Ltd. (NASDAQ:SLGL) traded up 5.2% during trading on Wednesday . The stock traded as high as $0.60 and last traded at $0.59. 11,111 shares traded hands during trading, a decline of 96% from the average session volume of 252,685 shares. The stock had previously closed at $0.56.

Sol-Gel Technologies Stock Up 5.2 %

The company’s 50-day moving average is $0.68 and its 200 day moving average is $0.69. The company has a market cap of $16.38 million, a price-to-earnings ratio of -1.73 and a beta of 1.29.

Hedge Funds Weigh In On Sol-Gel Technologies

An institutional investor recently bought a new position in Sol-Gel Technologies stock. Raymond James Financial Inc. acquired a new stake in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 108,990 shares of the company’s stock, valued at approximately $101,000. Raymond James Financial Inc. owned approximately 0.39% of Sol-Gel Technologies at the end of the most recent reporting period. 26.18% of the stock is owned by institutional investors and hedge funds.

Sol-Gel Technologies Company Profile

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.